Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial
- Conditions
- Fecal IncontinenceRectal CancerRectal NeoplasmsRectal Tumors
- Interventions
- Procedure: Side-to-End AnastomosisProcedure: Transverse Coloplasty
- Registration Number
- NCT03074461
- Lead Sponsor
- Ludwig-Maximilians - University of Munich
- Brief Summary
CSAR Trial's aim is to determine whether the transverse coloplasty pouch or the side-to-end anastomosis as rectal reservoir reconstruction offers the best functional results.
- Detailed Description
This study directly compares two neorectal reservoir-techniques, the transverse coloplasty and the side-to-end anastomosis, in low anterior resection in distal rectal cancer for the first time. Its focus is on the functional results. Besides stool frequency, the quality of life, safety of the procedures and the usage of stool modulating drugs is monitored in an 12 months-follow up regime.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Scheduled low anterior resection in patients with distal rectal carcinoma and planned anastomosis in mid/distal third of rectum
- Local curative approach
- Normal continence preoperatively
- Non-IBD-associated carcinoma
- Possible sphincter salvage
- Signed informed consent
- Non-curative approaches
- Emergency surgery in cases of tumor perforation, abscess, sepsis
- Proximal rectal carcinoma (> 12 cm from anocutaneous line)
- Lack of informed consent
- Age <18 years
- Inclusion in other trials with interference of endpoints
- Life expectancy less than 24 months (as estimated by the treating physicians)
- Pregnancy
- Immunosuppression
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Side-to-End Side-to-End Anastomosis Side-to-End Anastomosis as neorectal reconstruction technique in low anterior resection (LAR) Transverse Coloplasty Transverse Coloplasty Transverse Coloplasty pouch as neorectal reconstruction technique in low anterior resection (LAR)
- Primary Outcome Measures
Name Time Method Stool frequency time = 6 months postoperative Between group differences in stool frequency at t = 6 months postoperative
- Secondary Outcome Measures
Name Time Method Postoperative complications through study completion (an average of 12 months postoperative) * Septic intraabdominal complications related to anastomosis (anastomotic insufficiencies, suture insufficiencies, abscesses);
* Wound infectionQuality of Life baseline, postoperative (2-3 months, 6 months, 12 months) Quality of Life with focus on colorectally specialized questionnaires
Antimotility drug usage baseline, postoperative (2-3 months, 6 months, 12 months) Usage of antimotility drugs (e.g. loperamide) evaluated by standardized questionnaires
Trial Locations
- Locations (3)
Maria-Theresia-Klinik
🇩🇪München, Bayern, Germany
Krankenhaus Barmherzige Brüder München
🇩🇪München, Bayern, Germany
Klinikum der Universität München
🇩🇪München, Bayern, Germany